PKY Shares Pathkey.AI Ltd
ASX · ASXLast in our picks 2026-09-25 — not in the current list; analysis below is from that screen
Chip-related acquisition adds semiconductor exposure, but liquidity and proof points are limited.
Signal breakdown
- ▸Acquisition catalyst; early-stage integration and liquidity risk.
- ▾Below 50-day MA (-24.46%)
Is PKY a buy right now?
Trend: PKY is trading below the 50-day average (-50.00%), RSI 65 — neutral momentum, with a 3-month return of -50.00%.
Valuation & quality: Pathkey.AI Ltd trades on PEG 1.76, price-to-book 0.45; fundamentals show net margin 0.0%, return on equity -18.5%.
Analyst consensus: 1 analysts have a mean 12-month price target of A$0.15 (+900% vs the last close; range A$0.15 – A$0.15), consensus rating “none”.
Our screen: WATCH (score 0) — Chip-related acquisition adds semiconductor exposure, but liquidity and proof points are limited.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -33.30% | +150.00% | -20.00% | +75.00% | -57.10% | +33.30% | -25.00% | -66.70% |
Fundamentals
Analyst price target
Technical signals
About Pathkey.AI Ltd
Pathkey.AI Ltd, a technology company, develops agentic AI solutions in Australia. The company offers Chipforge, an AI-native semiconductor design and verification platform. It also provides Trialkey, an AI platform for clinical-trial design and prediction.
Sector: Healthcare · Industry: Health Information Services · Australia · Website
Related Semiconductors picks
Browse: all ASX stocks · Semiconductors picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.